Business Description
Leidos Holdings, Inc., along with its various subsidiaries, delivers a broad spectrum of services and innovative solutions across key markets: defense, intelligence, civil government, and health. The company operates both domestically within the United States and on an international scale. Its operations are organized into three principal divisions: Defense Solutions, Civil, and Health. The Defense Solutions segment is dedicated to providing national security systems and specialized support spanning air, land, sea, space, and cyberspace domains. Its extensive client base includes the U.S. Intelligence Community, the Department of Defense, NASA, various military branches, allied foreign governments, and other federal and commercial entities within the national security sector. This division's offerings encompass advanced technology, large-scale systems integration, command and control platforms, sophisticated data analytics, logistics, robust cybersecurity defenses, and crucial intelligence analysis and operational support for critical missions. The Civil segment offers systems integration capabilities primarily to air navigation service providers, such as the Federal Aviation Administration (FAA). This involves critical programs like En Route Automation Modernization (ERAM), Advanced Technology Oceanic Procedure (ATOP), Time Based Flow Management (TBFM), Terminal Flight Data Management (TFDM), GEO-7, and Future Flight Services, as well as developing enterprise-wide information display systems. Additionally, this segment provides security detection and automation services. Its portfolio further extends to comprehensive information technology (IT) solutions, covering areas like cloud computing, mobility, application modernization, DevOps, data center operations, network upgrades, asset management, help desk support, and digital workplace enablement. Environmental, energy, and infrastructure services also fall under this division. Finally, the Health segment furnishes solutions to both federal and commercial clients globally, focusing on initiatives that promote human health and well-being. This includes services such as health information management, managed healthcare programs, digital transformation projects, and support for life sciences research and development. Leidos Holdings, Inc. was established in 1969 and is based out of Reston, Virginia.
Business History
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 11.22
Total Equity: $4.92B
Shares: 132,411,067
Total Debt: $5.34B
Cash: $1.20B
EBITDA: $2.41B
Total Debt: $5.34B
Cash: $1.20B
Revenue: $17.17B
Revenue: $17.17B
Revenue: $17.17B
Total Equity: $4.92B
Tax Rate: 23.2%
Equity: $4.92B
Total Debt: $5.34B
Cash: $1.20B
Current Liabilities: $2.83B
Long-Term Debt: $5.22B
Total Debt: $5.34B
Total Equity: $4.92B
Shares: 132,411,067
Shares: 132,411,067
CapEx: -$125.00M
Shares: 132,411,067
Stock Price: $101.73
Net Income: $1.46B
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 7:57pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $13.7B | $14.4B | $15.4B | $16.7B | $17.2B |
| Cost of Revenue | $11.7B | $12.3B | $13.2B | $13.9B | $14.1B |
| Gross Profit | $2.0B | $2.1B | $2.2B | $2.8B | $3.0B |
| Operating Expenses | $862.0M | $996.0M | $1.6B | $971.0M | $925.9M |
| Operating Income | $1.2B | $1.1B | $621.0M | $1.8B | $2.1B |
| Net Income | $753.0M | $685.0M | $199.0M | $1.3B | $1.5B |
| EBITDA | $1.5B | $1.4B | $946.0M | $2.1B | $2.4B |
| EPS | $5.34 | $5.00 | $1.45 | $9.36 | $11.22 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 6:52pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $727.0M | $516.0M | $777.0M | $943.0M | $1.2B |
| Total Current Assets | $3.6B | $3.6B | $4.0B | $4.4B | $4.8B |
| Total Assets | $13.3B | $13.1B | $12.7B | $13.1B | $13.5B |
| Current Liabilities | $3.2B | $3.9B | $3.0B | $3.7B | $2.8B |
| Long-Term Debt | $4.6B | $3.9B | $4.7B | $4.1B | $5.2B |
| Total Liabilities | $8.9B | $8.7B | $8.4B | $8.6B | $8.5B |
| Total Equity | $4.3B | $4.3B | $4.2B | $4.4B | $4.9B |
| Retained Earnings | $1.9B | $2.4B | $2.4B | $3.4B | $4.6B |
Cash Flow (Annual)
Last updated: Jun 21, 2026 6:52pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $986.0M | $1.2B | $1.4B | $1.8B |
| Capital Expenditure | -$104.0M | -$129.0M | -$207.0M | -$149.0M | -$125.0M |
| Free Cash Flow | $927.0M | $857.0M | $958.0M | $1.2B | $1.6B |
| Acquisitions (net) | -$622.0M | -$177.0M | -$6.0M | $0 | -$300.0M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$270.0M | -$542.0M | -$246.0M | -$906.0M | -$944.0M |
| Net Change in Cash | $188.0M | -$192.0M | $245.0M | $156.0M | $213.0M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 11:20am (21h ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$17.3B $17.2B – $17.3B
|
$18.2B $17.9B – $18.5B
|
$19.1B $18.7B – $19.4B
|
$20.0B $20.0B – $20.0B
|
| EBITDA |
$3.2B $3.2B – $3.2B
|
$3.4B $3.3B – $3.4B
|
$3.5B $3.4B – $3.6B
|
$3.7B $3.7B – $3.7B
|
| Net Income |
$1.6B $1.5B – $1.6B
|
$1.6B $1.6B – $1.6B
|
$1.7B $1.7B – $1.8B
|
$1.9B $1.7B – $2.1B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:57pm (5d ago)| Metric | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue Growth | +4.8% | +7.2% | +7.9% | +3.1% |
| Gross Profit Growth | +3.5% | +7.7% | +24.7% | +8.4% |
| Operating Income Growth | -5.6% | -42.9% | +194.2% | +15.3% |
| Net Income Growth | -9.0% | -70.9% | +530.2% | +16.1% |
| EBITDA Growth | -3.9% | -33.3% | +124.3% | +13.4% |
Dividend History (Last 20)
Last updated: Jun 21, 2026 6:52pm (5d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-15 | $0.43 | 2026-05-01 | 2026-06-15 | 2026-06-30 |
| 2026-03-16 | $0.43 | 2026-02-13 | 2026-03-16 | 2026-03-31 |
| 2025-12-15 | $0.43 | 2025-10-31 | 2025-12-15 | 2025-12-31 |
| 2025-09-15 | $0.40 | 2025-08-01 | 2025-09-15 | 2025-09-30 |
| 2025-06-16 | $0.40 | 2025-05-02 | 2025-06-16 | 2025-06-30 |
| 2025-03-14 | $0.40 | 2025-02-07 | 2025-03-14 | 2025-03-28 |
| 2024-12-16 | $0.40 | 2024-10-25 | 2024-12-16 | 2024-12-31 |
| 2024-09-13 | $0.38 | 2024-07-26 | 2024-09-13 | 2024-09-27 |
| 2024-06-14 | $0.38 | 2024-04-26 | 2024-06-14 | 2024-06-28 |
| 2024-03-14 | $0.38 | 2024-02-08 | 2024-03-15 | 2024-03-28 |
| 2023-12-14 | $0.38 | 2023-10-27 | 2023-12-15 | 2023-12-29 |
| 2023-09-14 | $0.36 | 2023-07-28 | 2023-09-15 | 2023-09-29 |
| 2023-06-14 | $0.36 | 2023-04-28 | 2023-06-15 | 2023-06-30 |
| 2023-03-14 | $0.36 | 2023-02-10 | 2023-03-15 | 2023-03-31 |
| 2022-12-14 | $0.36 | 2022-10-28 | 2022-12-15 | 2022-12-30 |
| 2022-09-14 | $0.36 | 2022-07-29 | 2022-09-15 | 2022-09-30 |
| 2022-06-14 | $0.36 | 2022-04-29 | 2022-06-15 | 2022-06-30 |
| 2022-03-14 | $0.36 | 2022-02-11 | 2022-03-15 | 2022-03-31 |
| 2021-12-14 | $0.36 | 2021-10-29 | 2021-12-15 | 2021-12-30 |
| 2021-09-14 | $0.36 | 2021-07-30 | 2021-09-15 | 2021-09-30 |
Narrative Economics
market-narrative step).